Compare the Safety and Effectiveness of Genoss® DCB and SeQuent® Please NEO in Chinese Patients with Coronary ISR
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 224 participants.
Also called NCT04767022
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 224 participants
- Sponsor
- Registry
-
NCT04767022
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT04767022. Randomized; double masking; primary purpose treatment. Start 2021-01-30 (actual); primary completion 2023-12-20 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Compare the Safety and Effectiveness of Genoss® DCB and SeQuent® Please NEO in Chinese Patients with Coronary ISR
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Paclitaxel Coated PTCA Balloon Catheter(Genoss® DCB)
- Intervention (Device)
- Paclitaxel Coated PTCA Balloon Catheter(SeQuent® Please NEO)
- Lead sponsor
- Genoss Co., Ltd.
Record details
- Record id
cardio:ct-nct04767022- Content hash
f2a844960bd400ecaa9bcbeba094e63f66250e12dfdeef9851ce29d9041a795e